Hillhouse Investment Management, Ltd.
CIK: 0001510589
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVBP
ArriVent BioPharma, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About HILLHOUSE INVESTMENT MANAGEMENT, LTD.
HILLHOUSE INVESTMENT MANAGEMENT, LTD. (SEC CIK 0001510589) files insider reports with the SEC as 10% Owner of ArriVent BioPharma, Inc. (AVBP).
Signal8 holds 1 ownership filing by HILLHOUSE INVESTMENT MANAGEMENT, LTD., a Form 4, filed on Feb 3, 2026. Those filings report 1 transaction, the latest on Dec 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on HILLHOUSE INVESTMENT MANAGEMENT, LTD.'s filings is in GRAND CAYMAN, E9.
Recent filings by HILLHOUSE INVESTMENT MANAGEMENT, LTD.
- Dec 10, 2025: Open-market sale of AVBP shares (Form 4, code S).
Other insiders filing for ArriVent BioPharma, Inc. (AVBP)
- LaChapelle Robin, Chief Operating Officer
- Parsey Merdad, Director
- Peterson Kristine, Director
- Hohneker John, Director
- Nolet Chris, Director
- Lutzker Stuart, President of R&D